1 / 4

Immunoglobulin A (IgA) Nephropathy Market Growing at Healthy CAGR of 20 by 2029

IgA nephropathy is a kidney condition in which IgA, a protein that helps the body protect itself against external invaders, builds up in the kidneys and causes damage. This reduces their screening ability. As a result, the kidneys begin to leak chemicals into the urine, such as blood and protein. As a result, treatment options focus on controlling immunological and inflammatory processes in the glomerulus and tubulointerstitium. Therefore, many contemporary therapeutic techniques, such as renin-angiotensin blocking, proteinuria reduction, and blood pressure control, are applicable to various k

dbmr55
Download Presentation

Immunoglobulin A (IgA) Nephropathy Market Growing at Healthy CAGR of 20 by 2029

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Immunoglobulin A (IgA) Nephropathy Market Growing at Healthy CAGR of 20% by 2029 IgA nephropathy is a kidney condition in which IgA, a protein that helps the body protect itself against external invaders, builds up in the kidneys and causes damage. This reduces their screening ability. As a result, the kidneys begin to leak chemicals into the urine, such as blood and protein. As a result, treatment options focus on controlling immunological and inflammatory processes in the glomerulus and tubulointerstitium. Therefore, many contemporary therapeutic techniques, such as renin-angiotensin blocking, proteinuria reduction, and blood pressure control, are applicable to various kinds of chronic glomerular disorders. Data Bridge Market Research analyses that the immunoglobulin A (IgA) nephropathy market was valued at USD 85.68 million in 2021 and is expected to reach USD 370.87 million by 2029, registering a CAGR of 20.1% during the forecast period of 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework. Download Exclusive Sample Report @ https://www.databridgemarketresearch.com/request- a-sample/?dbmr=global-iga-nephropathy-market Market Analysis and Insights: Immunoglobulin A (IgA) Nephropathy Market: IgA nephropathy is a kidney disease caused by the accumulation of an antibody called immunoglobulin A (IgA) in the kidneys. This causes local inflammation, which can impair your kidneys' ability to filter waste from your blood over time. Several drugs can help manage symptoms and delay disease progression. Blood pressure can be lowered and protein loss reduced by taking angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs). Diuretics assist in the removal of excess fluid from the body. Extra fluid removal can help in blood pressure regulation. Corticosteroids, such as prednisone, and other powerful immune suppressants (immunosuppressants) may prevent your immune system from attacking your glomeruli in some situations. Immunoglobulin A (IgA) Nephropathy Market Scope and Market Size The immunoglobulin A (IgA) nephropathy market is segmented on the basis of treatment, diagnosis, disease type, symptoms, population type, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth

  2. segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications. Diagnosis  Iothalamate Clearance Test  Kidney Biopsy  Blood Tests  Urine Tests Disease Type  Primary IgA Nephropathy  Secondary IgA Nephropathy Symptoms  Hematuria  Proteinuria  Edema  Others Population Type  Pediatrics  Adults Route of Administration  Oral  Parenteral  Others Treatment  Medication  Statin therapy  Omega-3 fatty acids  Angiotensin-converting enzyme (ACE) inhibitors  Angiotensin receptor blockers (ARBs)  Diuretics  Immunosuppressants

  3. Kidney Transplantation  Others End-Users  Hospitals  Specialty Clinics  Homecare  Others Distribution Channel  Hospital Pharmacy  Retail Pharmacy  Online Pharmacy  Others Browse Full Report Along with Facts and Figures @ https://www.databridgemarketresearch.com/reports/global-iga-nephropathy-market Some Trending Reports of Healthcare Industry: Tracheostomy Products Market Tracheostomy Products Market Cell Based Assays Market Patient Derived Xenograft (PDX) Models Market Sleep Disorder Treatment Market Track and Trace Solutions Market About Us: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing sopan.gedam@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate. Contact Us: US: +1 888 387 2818

  4. UK: +44 208 089 1725 Hong Kong: +852 8192 7475 Email – corporatesales@databridgemarketresearch.com

More Related